Back to SUPN
ProShare Advisors LLC SUPN Position History
Supernus Pharmaceuticals, Inc. • Healthcare
Quarters held
5
Latest value
$763K
Q3 2026
Peak value
$763K
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $583K |
| Q4 2025 | $649K |
| Q1 2026 | $578K |
| Q2 2026 | $462K |
| Q3 2026 | $763K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $763K | 17.7K | — | — |
| Q2 2026 | $462K | 9.9K | — | — |
| Q1 2026 | $578K | 11.2K | — | — |
| Q4 2025 | $649K | 13.1K | — | — |
| Q3 2025 | $583K | 12.2K | — | — |
Other funds holding SUPN
$179.2M
$171.4M
$164.2M
$118.3M
$114.4M
$114.4M